Skip to main content




Richard A. Graham, Ph.D., is Senior Vice President, Research and Development at Theravance Biopharma, where he is responsible for leading the progression of therapeutic candidates through regulatory filing and approval. Since joining Theravance Biopharma, Dr. Graham has served as Vice President of Clinical Pharmacology, and as Senior Vice President of Development. Prior to joining Theravance Biopharma, Dr. Graham spent five years at GlaxoSmithKline working in Drug Metabolism and Pharmacokinetics, seven years at Genentech/Roche as a clinical pharmacologist and Global Development Team Leader, and one year at Onyx Pharmaceuticals, where he headed Translational Medicine.

In his 20+ year career, he has worked across all stages of drug development and all major therapeutic areas. Dr. Graham serves on the Board of Directors for the Eshelman School of Pharmacy Foundation and is a member of the Board of Advisors for TruLab Inc., a private software company, Caparna AI, a private software company and Med Aditus, a non-profit organization. Dr. Graham received his Bachelor’s and Master’s degree in Biochemistry from Iowa State University and his Doctorate of Philosophy degree in Pharmaceutical Sciences from The University of North Carolina at Chapel Hill.